meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.CD005195.PUB4 |
P953 | full work available at URL | https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005195.pub4/full |
P932 | PMC publication ID | 6491296 |
P698 | PubMed publication ID | 29376219 |
P50 | author | Cinzia Del Giovane | Q28325066 |
Tommaso Filippini | Q49620073 | ||
Maurice Zeegers | Q53390110 | ||
Marcel Zwahlen | Q55136094 | ||
Markus Horneber | Q56480750 | ||
Catherine M. Crespi | Q56635281 | ||
P2093 | author name string | G. Dennert | |
M. Brinkman | |||
R. D'Amico | |||
M. Vinceti | |||
P2860 | cites work | Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force | Q22241127 |
American Cancer Society guidelines on nutrition and physical activity for cancer prevention | Q22241237 | ||
Selenium supplementation for critically ill adults | Q24186311 | ||
Vitamin D supplementation for prevention of cancer in adults | Q24193850 | ||
Selenium for preventing cancer | Q24197798 | ||
Drugs for preventing lung cancer in healthy people | Q24198265 | ||
Selenium supplementation for the primary prevention of cardiovascular disease | Q24201670 | ||
Toenail and plasma levels as biomarkers of selenium exposure | Q81860973 | ||
The investigation of a geographical cluster of bladder cancer | Q83280653 | ||
Plasma selenium concentration and prostate cancer risk | Q83333597 | ||
Serum selenium levels are inversely associated with death risk among hemodialysis patients | Q83524652 | ||
Selenium intake and breast cancer mortality in a cohort of Swedish women | Q84465871 | ||
Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis | Q84593840 | ||
Ochsner cancer institute studies vitamin e and selenium as prostate cancer prevention agents | Q84608671 | ||
Differential responses to selenomethionine supplementation by sex and genotype in healthy adults | Q84971636 | ||
Selenium for preventing cancer | Q24234517 | ||
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases | Q24242944 | ||
Grading quality of evidence and strength of recommendations | Q24562409 | ||
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
Selenium and diabetes--evidence from animal studies | Q26821855 | ||
Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies | Q27012686 | ||
Friend or foe? The current epidemiologic evidence on selenium and human cancer risk | Q27015669 | ||
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Enough is enough: Stop wasting money on vitamin and mineral supplements | Q28307171 | ||
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts | Q28308282 | ||
A case-control study of the risk of cutaneous melanoma associated with three selenium exposure indicators | Q28728756 | ||
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias) | Q29619791 | ||
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 | ||
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29620308 | ||
Do environmental factors modify the genetic risk of prostate cancer? | Q30621007 | ||
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection | Q30777450 | ||
Selenium, an essential and toxic element. Latin American data | Q30835855 | ||
Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization | Q30836157 | ||
Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies | Q31112967 | ||
Trace elements in blood and serum of Swedish adolescents: relation to gender, age, residential area, and socioeconomic status | Q32126227 | ||
Histological and ultrastructural changes induced by selenium in early experimental gastric carcinogenesis | Q33220609 | ||
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials | Q33285346 | ||
Linkage of serum sample bank and cancer registry in epidemiological studies | Q33454035 | ||
Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study | Q33560612 | ||
A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival | Q33566592 | ||
A gene-environment interaction analysis of plasma selenium with prevalent and incident diabetes: The Hortega study | Q33599682 | ||
Serum antioxidant nutrients, vitamin A, and mortality in U.S. Adults | Q33631882 | ||
Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis | Q36267277 | ||
Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources | Q36288700 | ||
Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data | Q36459223 | ||
Are men with low selenium levels at increased risk of prostate cancer? | Q36582938 | ||
Organic selenium supplementation increased selenium concentrations in ewe and newborn lamb blood and in slaughter lamb meat compared to inorganic selenium supplementation | Q36593444 | ||
Toenail selenium concentrations and bladder cancer risk in women and men. | Q36615413 | ||
Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study | Q36629369 | ||
Soil-type influences human selenium status and underlies widespread selenium deficiency risks in Malawi | Q36676252 | ||
Antioxidant intake and pancreatic cancer risk: the Vitamins and Lifestyle (VITAL) Study | Q36703823 | ||
Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges | Q36769227 | ||
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival | Q36807029 | ||
Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis | Q36813967 | ||
Toward understanding success and failures in the use of selenium for cancer prevention | Q36945715 | ||
Influence of organic versus inorganic dietary selenium supplementation on the concentration of selenium in colostrum, milk and blood of beef cows | Q36979178 | ||
Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor | Q36994043 | ||
Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? | Q36994096 | ||
Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems | Q37002586 | ||
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran | Q37005294 | ||
Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms? | Q37074391 | ||
Meta-analysis of the association between selenium and gastric cancer risk | Q37085831 | ||
Selenium and risk of bladder cancer: a population-based case-control study | Q37093831 | ||
Food-chain selenium and human health: emphasis on intake | Q37112023 | ||
Spurious precision? Meta-analysis of observational studies | Q37150008 | ||
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. | Q37164902 | ||
Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort | Q37301131 | ||
Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study | Q37312101 | ||
Dietary selenium intake and mortality in two population-based cohort studies of 133 957 Chinese men and women | Q37338357 | ||
Cigarette smoking and prostate cancer in a prospective US cohort study | Q37343295 | ||
Selenium, folate, and colon cancer | Q37345589 | ||
Assessing and presenting summaries of evidence in Cochrane Reviews | Q37362186 | ||
Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study | Q37370148 | ||
Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention | Q37391753 | ||
The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status | Q37402147 | ||
DNA damage and oxidative stress response to selenium yeast in the non-smoking individuals: a short-term supplementation trial with respect to GPX1 and SEPP1 polymorphism | Q37438262 | ||
Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations | Q33652577 | ||
Health risk assessment of environmental selenium: Emerging evidence and challenges (Review) | Q33671643 | ||
Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. | Q33695740 | ||
A prospective study of dietary selenium intake and risk of type 2 diabetes | Q33698642 | ||
Micronutrient supplementation in adults with HIV infection. | Q33761301 | ||
Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison | Q33829606 | ||
Serum selenium concentration associated with risk of cancer | Q33839074 | ||
Dietary mineral intake and lung cancer risk: the Rotterdam Study | Q33841119 | ||
A prospective study of plasma Selenoprotein P and lung cancer risk among low-income adults | Q33848007 | ||
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer | Q33863562 | ||
Selenoproteins: molecular pathways and physiological roles. | Q33913069 | ||
Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer | Q33928521 | ||
The epidemiology of selenium and human cancer | Q33944217 | ||
A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation | Q34013434 | ||
Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial | Q34016998 | ||
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up | Q34044105 | ||
A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). | Q34135313 | ||
SELECT: the selenium and vitamin E cancer prevention trial | Q34189351 | ||
Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer | Q34277961 | ||
Selenium intake and selenium blood levels: a novel food frequency questionnaire. | Q34333878 | ||
Dietary antioxidants and the aetiology of pancreatic cancer: a cohort study using data from food diaries and biomarkers | Q34349240 | ||
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals | Q34370181 | ||
The association between selenium and other micronutrients and thyroid cancer incidence in the NIH-AARP Diet and Health Study | Q34374520 | ||
Selenium and vitamin E cancer prevention trial | Q34400897 | ||
Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement | Q34406541 | ||
Toenail selenium status and the risk of Barrett's esophagus: the Netherlands Cohort Study | Q34427675 | ||
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer | Q34469841 | ||
Selenium and Human Health: Witnessing a Copernican Revolution? | Q34480665 | ||
Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data | Q34489507 | ||
Selenium and human health. | Q34636304 | ||
Adverse health effects of selenium in humans | Q34663990 | ||
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT. | Q34959029 | ||
Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. | Q34977797 | ||
Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients | Q42509221 | ||
Serological precursors of cancer: malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, beta- carotene, lycopene, alpha-tocopherol, and selenium. | Q42517829 | ||
Intake of antioxidant nutrients and the risk of skin cancer | Q42521280 | ||
Diet and basal cell skin cancer: results from the EPIC-Norfolk cohort | Q42522550 | ||
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | Q42528232 | ||
Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study | Q42528740 | ||
Relationship between glaucoma and selenium levels in plasma and aqueous humour | Q42659241 | ||
Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men. | Q43460354 | ||
Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers | Q43465804 | ||
Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study | Q43507505 | ||
Micronutrients and the risk of lung cancer | Q43644826 | ||
Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: Summary of findings. | Q43711046 | ||
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). | Q43734407 | ||
Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. | Q43757397 | ||
Plasma selenium level before diagnosis and the risk of prostate cancer development | Q43790830 | ||
Cancer incidence and mortality among Swedish Baltic Sea fishermen | Q44039236 | ||
The nutritional prevention of cancer: 400 mcg per day selenium treatment | Q44134098 | ||
Prospective study of serum micronutrients and ovarian cancer | Q44215642 | ||
Prediagnostic toenail selenium and risk of bladder cancer. | Q44217792 | ||
Prevention and early detection clinical trials: opportunities for primary care providers and their patients | Q44400677 | ||
Selenium and vitamin E supplementation for cancer prevention | Q44405788 | ||
Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third National Health and Nutrition Examination Survey, 1988-1994. | Q44446631 | ||
Is low selenium status a risk factor for lung cancer? | Q44694025 | ||
Serum selenium and cancer mortality: a nested case-control study within an age- and sex-stratified sample of the Belgian adult population | Q44696058 | ||
Nutrient intake and gastric cancer in residents of Zhoushan Islands, China | Q44712160 | ||
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials | Q44720982 | ||
Advanced prostate cancer risk in relation to toenail selenium levels | Q44786239 | ||
Voluntary food fortification in the United States: potential for excessive intakes | Q44853681 | ||
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? | Q44907034 | ||
Identification and synthesis of a novel selenium-sulfur amino acid found in selenized yeast: Rapid indirect detection NMR methods for characterizing low-level organoselenium compounds in complex matrices | Q44928233 | ||
Toenail selenium levels and the risk of breast cancer | Q44990009 | ||
Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk | Q45022347 | ||
An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. | Q45054163 | ||
Selenium status and chronic disease mortality: Dutch epidemiological findings | Q45068345 | ||
Prostate disease risk factors among a New Zealand cohort | Q45330916 | ||
Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection | Q45747720 | ||
Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong | Q45762995 | ||
Dietary supplements and human health: for better or for worse? | Q45893090 | ||
Selenium speciation in paired serum and cerebrospinal fluid samples. | Q46025832 | ||
Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer | Q46181790 | ||
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). | Q46209509 | ||
The role of antioxidants and vitamin A in ovarian cancer: results from the Women's Health Initiative | Q46249629 | ||
Elevated Levels of Selenium Species in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients with Disease-Associated Gene Mutations | Q46370548 | ||
Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer | Q46395715 | ||
Tracing cytotoxic effects of small organic Se species in human liver cells back to total cellular Se and Se metabolites. | Q46420200 | ||
Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: the Rotterdam Study | Q46555408 | ||
Selenium and Vitamin E Cancer Prevention Trial--this one's for us. | Q46616064 | ||
Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib | Q46687811 | ||
Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. | Q46709847 | ||
Comparative toxicosis of sodium selenite and selenomethionine in lambs | Q46762886 | ||
The West Midlands Bladder Cancer Prognosis Programme: rationale and design. | Q39947406 | ||
Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort | Q40162854 | ||
Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia. | Q40203271 | ||
Whole blood mercury and selenium concentrations in a selected Austrian population: does gender matter? | Q40289795 | ||
Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG. | Q40373848 | ||
Dietary trace element intake and liver cancer risk: Results from two population-based cohorts in China | Q40446599 | ||
Never smokers and lung cancer risk: a case-control study of epidemiological factors. | Q40496740 | ||
Prospective study of toenail selenium levels and cancer among women | Q40500943 | ||
Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. | Q40560645 | ||
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. | Q40619759 | ||
More results but no clear conclusion on selenium and cancer | Q40652244 | ||
Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort | Q40675361 | ||
Long-term mortality patterns in a residential cohort exposed to inorganic selenium in drinking water | Q40682065 | ||
Selenoprotein P in plasma in relation to cancer morbidity in middle-aged Swedish men. | Q40766358 | ||
Self-Reporting of Smoking Cessation in Cardiac Patients: How Reliable Is It and Is Reliability Associated With Patient Characteristics? | Q40827032 | ||
Selenium status and risk of prostate cancer in a Danish population | Q40856718 | ||
Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study | Q41074658 | ||
Serum selenium and subsequent risk of cancer among Finnish men and women | Q41228887 | ||
A prospective study of selenium status and breast cancer risk | Q41237727 | ||
Association between serum selenium and the risk of cancer | Q41576736 | ||
Serum selenium and coronary heart disease risk factors in southern Italian men. | Q41761406 | ||
Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. | Q41817626 | ||
A re-evaluation of random-effects meta-analysis. | Q41866179 | ||
Dietary antioxidants and the risk of lung cancer | Q41910514 | ||
Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer | Q42003524 | ||
Reduction of cancer risk with an oral supplement of selenium | Q42444945 | ||
Reduction of cancer mortality and incidence by selenium supplementation | Q42445824 | ||
Selenium Supplementation and Secondary Prevention of Nonmelanoma Skin Cancer in a Randomized Trial | Q42450899 | ||
Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study | Q42451656 | ||
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial | Q42456979 | ||
Comparative effects of high dietary levels of organic and inorganic selenium on selenium toxicity of growing-finishing pigs | Q42503509 | ||
The Epidemiology of Selenium and Human Cancer | Q58800438 | ||
Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes | Q58829111 | ||
Prediagnostic Level of Serum Retinol in Relation to Reduced Risk of Hepatocellular Carcinoma | Q59099512 | ||
The need for a reassessment of the safe upper limit of selenium in drinking water | Q60641274 | ||
A prospective cohort study on selenium status and the risk of lung cancer | Q61646446 | ||
A Prospective Cohort Study on Toenail Selenium Levels and Risk of Gastrointestinal Cancer | Q61646449 | ||
Effects of Smoking and Antioxidant Micronutrients on Risk of Colorectal Cancer | Q61858415 | ||
Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. | Q64888522 | ||
A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China | Q67714945 | ||
SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design | Q35032568 | ||
The selenium and vitamin E cancer prevention trial | Q35131287 | ||
Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial. | Q35194287 | ||
Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study | Q35291291 | ||
Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis | Q35316267 | ||
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. | Q35528860 | ||
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). | Q35534236 | ||
Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study | Q35547580 | ||
Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial | Q35603819 | ||
Redox-active selenium compounds--from toxicity and cell death to cancer treatment | Q35658137 | ||
Selenium and chronic diseases: a nutritional genomics perspective | Q35658168 | ||
Is the inverse association between selenium and bladder cancer due to confounding by smoking? | Q35661856 | ||
Serum selenium and risk of prostate cancer-a nested case-control study | Q35728992 | ||
Accuracy of self-reported tobacco use in newly diagnosed cancer patients | Q35770231 | ||
Dietary intake of minerals and risk of esophageal squamous cell carcinoma: results from the Golestan Cohort Study | Q35781238 | ||
Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1. | Q35800890 | ||
Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study. | Q35809064 | ||
The globalization of epidemiology: introductory remarks | Q35817598 | ||
Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women | Q35822203 | ||
Possible protective effect of selenium against human cancer | Q35935388 | ||
The use of high-selenium yeast to raise selenium status: how does it measure up? | Q35937196 | ||
Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer | Q35945058 | ||
Redox-modulatory vitamins and minerals that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of people aged 65 years and over | Q35990722 | ||
Dietary Selenium Levels Affect Selenoprotein Expression and Support the Interferon-γ and IL-6 Immune Response Pathways in Mice | Q36012410 | ||
Racial/ethnic differences in lifestyle-related factors and prostate cancer risk: the Multiethnic Cohort Study | Q36054387 | ||
A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet | Q36108172 | ||
Mechanistic aspects of the interaction between selenium and arsenic | Q36139706 | ||
Role of dietary factors in the development of basal cell cancer and squamous cell cancer of the skin. | Q36200691 | ||
Serum vitamin E, serum selenium and the risk of gastrointestinal cancer | Q67970496 | ||
Protective effects of selenium, zinc and copper on lung cancer | Q68021440 | ||
Serum selenium level in relation to in situ cervical cancer in Australia | Q68194998 | ||
Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study | Q68285569 | ||
Predictors of selenium concentration in human toenails | Q68822822 | ||
Serum selenium and risk of cancer. A prospective follow-up of nine years | Q69053713 | ||
Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project | Q69136487 | ||
Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer | Q69606956 | ||
Prediagnostic serum selenium in a case-control study of thyroid cancer | Q69612323 | ||
Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer | Q69647878 | ||
Is serum selenium a risk factor for cancer in men only? | Q69681102 | ||
Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer | Q69746887 | ||
Low plasma selenium as a risk factor for cancer death in middle-aged men | Q70375237 | ||
Serum micronutrients and the subsequent risk of oral and pharyngeal cancer | Q70548986 | ||
Selenium and the risk of postmenopausal breast cancer in the DOM cohort | Q70779509 | ||
Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake | Q71502710 | ||
Re: Prospective study of serum micronutrients and ovarian cancer | Q71580173 | ||
Information on the selenium status of several body compartments of rats from the selenium concentrations in blood fractions, hair and nails | Q71753088 | ||
Comparative toxicity of selenium from seleno-DL-methionine, sodium selenate, and Astragalus bisulcatus in pigs | Q71784133 | ||
Urinary Selenium Status of Healthy People | Q71859983 | ||
The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers | Q72314019 | ||
Prediagnostic serum selenium and risk of cancer | Q72556164 | ||
Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study | Q72910646 | ||
Generational differences in selenium status of women | Q73123330 | ||
Prospective study of serum selenium levels and incident esophageal and gastric cancers | Q73141193 | ||
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial | Q73280460 | ||
Validity of a Self-administered Food Frequency Questionnaire Used in the 5-year Follow-up Survey of the JPHC Study to Assess Selenium Intake: Comparison with Dietary Records and Blood Levels | Q73286809 | ||
The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity | Q73875299 | ||
The relation between serum selenium value and cancer in Miyagi, Japan: 5-year follow up study | Q74059378 | ||
Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States) | Q74256162 | ||
Enrollment begins for largest-ever prostate cancer prevention trial | Q74299712 | ||
Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial | Q74420302 | ||
SELECT (opportunity for prostate cancer prevention) | Q74538327 | ||
Prostate cancer prevention trial launched | Q74599820 | ||
Largest-ever prostate cancer prevention trial | Q77132292 | ||
Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer | Q77156174 | ||
Passive smoking at home and cancer risk: a population-based prospective study in Japanese nonsmoking women | Q77195875 | ||
[The prevention of primary liver cancer by selenium in high risk populations] | Q77677467 | ||
Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene | Q79439596 | ||
Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults | Q80771594 | ||
Selenium and mortality in the elderly: results from the EVA study | Q81117993 | ||
Etiology and prevention of gastric cancer: a population study in a high risk area of China | Q81396511 | ||
Selenium status of the Swiss population: assessment and change over a decade | Q81483566 | ||
Low serum selenium and total carotenoids predict mortality among older women living in the community: the women's health and aging studies | Q81645299 | ||
Toenail selenium and risk of type 2 diabetes: the ORDET cohort study | Q46845927 | ||
Sun exposure, diet, and melanoma in Hawaii Caucasians | Q46981334 | ||
A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: effects on oxidative defence regulation. | Q46987477 | ||
Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention | Q47137343 | ||
A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment | Q47161769 | ||
A prospective study of plasma selenium levels and prostate cancer risk | Q47650692 | ||
Relationships between selenium, lipids, iron status and hormonal therapy in women of the SU.VI.M.AX cohort | Q47972831 | ||
Selenium and breast cancer risk: A prospective nested case-control study on serum selenium levels, smoking habits and overweight. | Q48169219 | ||
Serum micronutrients and risk of cancers of low incidence in Finland | Q48672366 | ||
Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial. | Q49168409 | ||
Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer. | Q50460749 | ||
Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. | Q50545977 | ||
Oxidative balance score and risk of prostate cancer: results from a case-cohort study. | Q50552103 | ||
Long-term selenium supplementation of humans: selenium status and relationships between selenium concentrations in skeletal muscle and indicator materials. | Q50579867 | ||
Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. | Q50859768 | ||
Determination of selenium in the serum of healthy Swiss adults and correlation to dietary intake. | Q51011387 | ||
The favourable effects of long-term selenium supplementation on regression of cervical tissues and metabolic profiles of patients with cervical intraepithelial neoplasia: a randomised, double-blind, placebo-controlled trial. | Q51295994 | ||
Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. | Q51920516 | ||
No Association between toenail selenium levels and bladder cancer risk. | Q52028465 | ||
Serum selenium and subsequent risk of prostate cancer. | Q52073446 | ||
Chemoprotective and chemosensitizing properties of selenium nanoparticle (Nano-Se) during adjuvant therapy with cyclophosphamide in tumor-bearing mice. | Q52845999 | ||
Ethnicity is an independent correlate of biomarkers of micronutrient intake and status in American adults. | Q53029158 | ||
A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues. | Q53399836 | ||
Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). | Q53453910 | ||
Selenium in human mammary carcinogenesis: a case-cohort study | Q53502445 | ||
Essential micronutrients in relation to carcinogenesis. | Q53529511 | ||
Toenail selenium concentration and lung cancer in male smokers (Finland). | Q53658814 | ||
Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. | Q53662880 | ||
Is serum selenium a risk factor for cancer? | Q53903662 | ||
Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. | Q54287099 | ||
Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. | Q54346269 | ||
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. | Q55035197 | ||
Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort | Q57026139 | ||
Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death | Q57481354 | ||
Serum tocopherols, selenium and lung cancer risk among tin miners in China | Q58299871 | ||
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q58394582 | ||
Methods of assessment of selenium status in humans: a systematic review. | Q37472521 | ||
Prostate cancer risk related to foods, food groups, macronutrients and micronutrients derived from the UK Dietary Cohort Consortium food diaries | Q37560094 | ||
Selenium and selenocysteine: roles in cancer, health, and development | Q37619604 | ||
Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry | Q37627799 | ||
Baseline comorbidities in a skin cancer prevention trial in Bangladesh | Q37635891 | ||
Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors | Q37672887 | ||
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk | Q37683660 | ||
Selenium in human health and disease | Q37784804 | ||
Surveying selenium speciation from soil to cell—forms and transformations | Q37800830 | ||
Medical geology of arsenic, selenium and thallium in China | Q37858117 | ||
Selenium interactions and toxicity: a review. Selenium interactions and toxicity | Q37931095 | ||
The properties, functions, and use of selenium compounds in living organisms. | Q38042667 | ||
Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials | Q38097254 | ||
Is selenium a potential treatment for cancer metastasis? | Q38097279 | ||
EURRECA-Estimating selenium requirements for deriving dietary reference values | Q38129415 | ||
Selenium and cancer: a story that should not be forgotten-insights from genomics | Q38151532 | ||
Selenium compounds as therapeutic agents in cancer. | Q38280346 | ||
Selenium and vitamin E for prostate cancer--justifications for the SELECT study | Q38411806 | ||
Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). | Q38455272 | ||
Cancer mortality correlation studies--III: statistical associations with dietary selenium intakes | Q38564567 | ||
Methylseleninic acid and sodium selenite induce severe ER stress and subsequent apoptosis through UPR activation in PEL cells. | Q38717956 | ||
Nail Selenium Level and Diabetes in Older People in Rural China | Q38780086 | ||
Selenium and redox signaling | Q38919874 | ||
Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis | Q38972096 | ||
Long-term selenium supplementation in HaCaT cells: importance of chemical form for antagonist (protective versus toxic) activities | Q39138885 | ||
Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE). | Q39187895 | ||
Antioxidants and basal cell carcinoma of the skin: a nested case-control study. | Q39237688 | ||
Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies | Q39265179 | ||
Toenail selenium as an indicator of selenium intake among middle-aged men in an area with low soil selenium | Q39414141 | ||
The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study | Q39466118 | ||
Serum levels of selenium and retinol and the subsequent risk of cancer | Q39520493 | ||
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up | Q39626332 | ||
Serum selenium levels in the US population: Third National Health and Nutrition Examination Survey, 1988-1994. | Q39647892 | ||
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women | Q39648674 | ||
Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China | Q39707585 | ||
P304 | page(s) | CD005195 | |
P577 | publication date | 2018-01-29 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Selenium for preventing cancer | |
P478 | volume | 1 |
Search more.